DuPont De Nemours (DD) Q1 2026 earnings summary

Executive summary

• Net sales for Q1 2026 reached $1.68 billion, up 4% year-over-year, driven by 2% organic growth and 2% currency benefit, led by healthcare and aerospace, partially offset by construction softness and Middle East disruptions.

• Operating EBITDA rose 15% to $414 million, with margin expansion to 24.6%; adjusted EPS increased 53% to $0.55.

• Completed Aramids business divestiture on April 1, 2026, for $1.2 billion in cash, a $300 million note, and $325 million equity interest; Electronics business separated in November 2025.

• Announced $275 million accelerated share repurchase as part of a $2 billion buyback program, with $500 million completed.

• Advanced sustainability goals, including a 76% reduction in Scopes 1 & 2 emissions since 2019, and launched 2035 targets.

Financial highlights

• Net sales: $1.68 billion (+4% YoY); organic sales +2%, currency +2%.

• Operating EBITDA: $414 million (+15% YoY); margin 24.6% (+230 bps YoY).

• Adjusted EPS: $0.55 (+53% YoY); pro forma adjusted EPS +20%.

• Transaction-adjusted free cash flow: $147 million; conversion rate 65%.

• Cash from operations: $232 million; CapEx: $102 million.

Outlook and guidance

• Full year 2026 guidance raised: net sales $7.155–$7.22 billion, operating EBITDA $1.73–$1.76 billion, adjusted EPS $2.35–$2.40, assuming 4% organic growth and 1% from pricing actions.

• Second quarter 2026 guidance: net sales ~$1.8 billion, operating EBITDA ~$430 million, adjusted EPS ~$0.59.

• Guidance assumes current Middle East conflict conditions persist through year-end.

• Segment expectations: Healthcare & Water Technologies to see mid-single digit organic growth; Diversified Industrials to see low-single digit growth.

• 2026 restructuring program targets $100–$150 million in pre-tax charges and cost savings through 2028.